{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:50:15Z","timestamp":1792363815602,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016879","name":"Union Chimique Belge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.heliyon.2023.e16415","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:58:48Z","timestamp":1684468728000},"page":"e16415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antiparkinsonian medication masks motor signal progression in de novo patients"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0079-4934","authenticated-orcid":false,"given":"Maksymilian A.","family":"Brzezicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6666-2208","authenticated-orcid":false,"given":"Niall","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9198-2067","authenticated-orcid":false,"given":"Charalampos","family":"Sotirakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-3834","authenticated-orcid":false,"given":"Chrystalina A.","family":"Antoniades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e16415_bib1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"Movement Disorder Society Evidence-Based Medicine Committee, International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e16415_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2012.03866.x","article-title":"Summary of the recommendations of the EFNS\/MDS-ES review on therapeutic management of Parkinson's disease","volume":"20","author":"Ferreira","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.heliyon.2023.e16415_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.28339","article-title":"Estimating the effect of early treatment initiation in Parkinson's disease using observational data","volume":"36","author":"van den Heuvel","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e16415_bib4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.23581","article-title":"Parkinson Study Group DATATOP and PRECEPT investigators, Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts","volume":"26","author":"Marras","year":"2011","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.heliyon.2023.e16415_bib5","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/mds.20640","article-title":"Unified Parkinson's disease rating scale motor examination: are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable?","volume":"20","author":"Post","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e16415_bib6","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/mds.27790","article-title":"Measuring Parkinson's disease over time: the real-world within-subject reliability of the MDS-UPDRS","volume":"34","author":"Evers","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e16415_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00202","article-title":"Quantifying motor impairment in movement disorders","volume":"12","author":"FitzGerald","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.heliyon.2023.e16415_bib8","first-page":"S35","article-title":"Body-worn sensors for remote monitoring of Parkinson's disease motor symptoms: vision, state of the art, and challenges ahead","volume":"11","author":"Del Din","year":"2021","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.heliyon.2023.e16415_bib9","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/mdc3.13334","article-title":"Strategy adherence: a specific and rapidly progressive deficit in progressive supranuclear palsy","volume":"8","author":"Brzezicki","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.heliyon.2023.e16415_bib10","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/mds.29194","article-title":"Longitudinal monitoring of progressive supranuclear palsy using body-worn movement sensors","volume":"37","author":"Sotirakis","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e16415_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.gaitpost.2020.02.007","article-title":"Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning","volume":"77","author":"De Vos","year":"2020","journal-title":"Gait Posture"},{"key":"10.1016\/j.heliyon.2023.e16415_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.parkreldis.2019.09.029","article-title":"The effect of levodopa on saccades \u2013 Oxford Quantification in Parkinsonism study","volume":"68","author":"Lu","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.heliyon.2023.e16415_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2012-304200a.39","article-title":"Impaired antisaccades in Parkinson's disease","volume":"83","author":"Antoniades","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e16415_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1109\/JBHI.2019.2903627","article-title":"Assessment of motor impairments in early untreated Parkinson's disease patients: the wearable electronics impact","volume":"24","author":"Ricci","year":"2020","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"10.1016\/j.heliyon.2023.e16415_bib15","first-page":"1","article-title":"Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson's disease cohort","volume":"7","author":"Di Lazzaro","year":"2021","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.heliyon.2023.e16415_bib16","doi-asserted-by":"crossref","DOI":"10.1109\/JBHI.2022.3160103","article-title":"The impact of wearable electronics in assessing the effectiveness of levodopa treatment in Parkinsons disease","author":"Ricci","year":"2022","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"10.1016\/j.heliyon.2023.e16415_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.gaitpost.2012.04.010","article-title":"Postural sway as a marker of progression in Parkinson's disease: a pilot longitudinal study","volume":"36","author":"Mancini","year":"2012","journal-title":"Gait Posture"},{"key":"10.1016\/j.heliyon.2023.e16415_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primer."},{"key":"10.1016\/j.heliyon.2023.e16415_bib19","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/brain\/awy155","article-title":"Neurophysiological correlates of bradykinesia in Parkinson's disease","volume":"141","author":"Bologna","year":"2018","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.heliyon.2023.e16415_bib20","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/124.11.2131","article-title":"Pathophysiology of bradykinesia in Parkinson's disease","volume":"124","author":"Berardelli","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.heliyon.2023.e16415_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(19)30044-4","article-title":"Gait impairments in Parkinson's disease","volume":"18","author":"Mirelman","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2023.e16415_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.11138\/FNeur\/2017.32.1.028","article-title":"Gait analysis and clinical correlations in early Parkinson's disease","volume":"32","author":"Pistacchi","year":"2017","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.heliyon.2023.e16415_bib23","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/mds.26720","article-title":"Arm swing as a potential new prodromal marker of Parkinson's disease","volume":"31","author":"Mirelman","year":"2016","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.heliyon.2023.e16415_bib24","first-page":"757","article-title":"Parkinson's disease drug therapies in the clinical trial pipeline: 2020","volume":"10","author":"McFarthing","year":"2020","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.heliyon.2023.e16415_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJMoa1809983","article-title":"Randomized delayed-start trial of levodopa in Parkinson's disease","volume":"380","author":"Verschuur","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e16415_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pneurobio.2016.07.002","article-title":"Expanding the repertoire of L-DOPA\u2019s actions: a comprehensive review of its functional neurochemistry","volume":"151","author":"De Deurwaerd\u00e8re","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.heliyon.2023.e16415_bib27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jnnp.74.7.844","article-title":"Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease","volume":"74","author":"Hershey","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e16415_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pneurobio.2011.06.005","article-title":"L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease?","volume":"94","author":"Lipski","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.heliyon.2023.e16415_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/mds.26119","article-title":"Levodopa: effect on cell death and the natural history of Parkinson's disease","volume":"30","author":"Olanow","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e16415_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2022.939677","article-title":"Oculomotor deficits in Parkinson's disease: increasing sensitivity using multivariate approaches","volume":"4","author":"Bredemeyer","year":"2022","journal-title":"Front. Digit. Health."},{"key":"10.1016\/j.heliyon.2023.e16415_bib31","series-title":"Oxford Textbook of Movement Disorders","author":"Burn","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e16415_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.parkreldis.2011.05.010","article-title":"Trunk accelerometry reveals postural instability in untreated Parkinson's disease","volume":"17","author":"Mancini","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.heliyon.2023.e16415_bib33","first-page":"1","article-title":"The emerging postural instability phenotype in idiopathic Parkinson disease","volume":"8","author":"Skidmore","year":"2022","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.heliyon.2023.e16415_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1109\/TBME.2006.886670","article-title":"Quantification of tremor and bradykinesia in Parkinson's disease using a novel ambulatory monitoring system","volume":"54","author":"Salarian","year":"2007","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.heliyon.2023.e16415_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp.2008.159699","article-title":"Segmental progression of early untreated Parkinson's disease: a novel approach to clinical rating","volume":"81","author":"Sch\u00fcpbach","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e16415_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gaitpost.2017.06.266","article-title":"Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length","volume":"58","author":"Kwon","year":"2017","journal-title":"Gait Posture"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023036228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023036228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:32:15Z","timestamp":1790469135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023036228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2405844023036228"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16415","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiparkinsonian medication masks motor signal progression in de novo patients","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e16415"}}